PRASUN JALAL to Risk Assessment
This is a "connection" page, showing publications PRASUN JALAL has written about Risk Assessment.
Connection Strength
0.135
-
Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2025 Feb; 23(2):281-290.e4.
Score: 0.031
-
The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure. J Hepatol. 2023 09; 79(3):717-727.
Score: 0.028
-
International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients. J Viral Hepat. 2022 09; 29(9):807-816.
Score: 0.026
-
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma. Gastroenterology. 2019 11; 157(5):1253-1263.e2.
Score: 0.022
-
Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2017 Nov; 15(11):1791-1799.
Score: 0.019
-
Use of a novel transluminal balloon accessotome in transmural drainage of pancreatic pseudocyst (with video). Gastrointest Endosc. 2008 Aug; 68(2):362-5.
Score: 0.010